Cenestin
Product Images NDC 54868-4879

14 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Cenestin (NDC 54868-4879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cenestin® 1.25 mg Packaging Label (1432)

Cenestin® 1.25 mg Packaging Label (1432)
Cenestin 1.25 mg tablet bottle label by Physicians Total Care, Inc. The label shows the active ingredient as synthetic conjugated estrogens, with a quantity of 30 tablets per bottle. Includes usage and storage cautions, barcode, and lot and expiration date information.*
FDA Label Image

Structural Formulae Sodium Estrone Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 01)

Structural Formulae Sodium Estrone Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 01)
Chemical structure diagram of Cenestin showing the molecular formula C18H21NaO5S and its sulfate group attached to a steroid backbone.*
FDA Label Image

Structural Formulae Sodium 17α-dihydroequilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 02)

Structural Formulae Sodium 17α-dihydroequilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 02)
Chemical structure diagram of the active ingredient in Cenestin, showing a steroid backbone with hydroxyl and sulfonate functional groups, and molecular formula components including Na, O, S, and C atoms.*
FDA Label Image

Structural Formulae Sodium 17α-estradiol Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 03)

Structural Formulae Sodium 17α-estradiol Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 03)
Chemical structure of the active ingredient in Cenestin, showing a steroidal skeleton with a hydroxyl group and a sulfonate group attached to a benzene ring; the molecular formula is C18H23NaO5S and molecular weight is 374.44.*
FDA Label Image

Structural Formulae Sodium Equilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 04)

Structural Formulae Sodium Equilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 04)
Chemical structure of Cenestin illustrating its molecular framework with labeled chemical formula and molecular weight.*
FDA Label Image

Structural Formulae Sodium 17β-dihydroequilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 05)

Structural Formulae Sodium 17β-dihydroequilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 05)
Chemical structure of the active ingredient in Cenestin, showing its molecular formula C18H19NaO5S with a molecular weight of 370.41. The structure includes a steroid backbone with a sulfate group (NaO3SO) attached to an aromatic ring and a hydroxyl group (OH) on the ring structure.*
FDA Label Image

Structural Formulae Sodium Equilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 06)

Structural Formulae Sodium Equilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 06)
Chemical structure diagram of the active ingredient for Cenestin, showing the molecular formula C18H19NaO5S and molecular weight 370.41.*
FDA Label Image

Structural Formulae Sodium 17β-dihydroequilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 07)

Structural Formulae Sodium 17β-dihydroequilin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 07)
Chemical structure diagram of the active ingredient in Cenestin, showing a steroid skeleton with hydroxyl and sulfonate groups. The molecular formula C18H21NaO5S and molecular weight 372.42 are indicated below the structure.*
FDA Label Image

Structural Formulae Sodium 17β-estradiol Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 08)

Structural Formulae Sodium 17β-estradiol Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 08)
Chemical structure diagram of the active ingredient commonly associated with Cenestin, showing molecular arrangement with atoms and bonds, including sulfate and hydroxyl groups, and molecular formula C18H23NaO5S with molecular weight 374.44.*
FDA Label Image

Structural Formulae Sodium 17α-dihydroequilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 09)

Structural Formulae Sodium 17α-dihydroequilenin Sulfate (410f9433 98ed 4c3f Abb1 2386296d2f72 09)
Chemical structure diagram of the active ingredient for Cenestin, showing a steroid-like framework with attached hydroxyl (OH) and sodium sulfonate (NaO3SO) groups, and its molecular formula C18H19NaO5S with molecular weight 370.41.*
FDA Label Image

Figure 1: Graph Of Mean Plasma Concentration Of Unconjugated Estrogens After A 2 X 0.625 mg Cenestin Dose Under Fasting Conditions (410f9433 98ed 4c3f Abb1 2386296d2f72 10)

Figure 1: Graph Of Mean Plasma Concentration Of Unconjugated Estrogens After A 2 X 0.625 mg Cenestin Dose Under Fasting Conditions (410f9433 98ed 4c3f Abb1 2386296d2f72 10)
A line graph showing mean plasma concentration (pg/mL) of unconjugated estrogens (estrone and equilin) over time (hours) after a single 0.625 mg dose of Cenestin under fasting conditions. The x-axis shows time from dosing, and the y-axis shows plasma concentration with estrone and equilin represented by separate curves.*
FDA Label Image

Figure 2: Graphical Summary Of % Superficial Cells Results In Patients Following 16 Weeks Of Treatment With Cenestin 0.3mg Mean +/- Se (410f9433 98ed 4c3f Abb1 2386296d2f72 11)

Figure 2: Graphical Summary Of % Superficial Cells Results In Patients Following 16 Weeks Of Treatment With Cenestin 0.3mg Mean +/- Se (410f9433 98ed 4c3f Abb1 2386296d2f72 11)
A line graph titled 'Summary of % Superficial Cells Results in Patients Following 16 Weeks of Treatment with Cenestin 0.3 mg Mean +/- SE' comparing the percentage of superficial cells over 16 weeks between Cenestin 0.3 mg and placebo. The graph shows data at 0, 4, 8, 12, and 16 weeks of treatment, with Cenestin demonstrating a higher percentage increase in superficial cells compared to placebo over time.*
FDA Label Image

Cenestin® 0.625 mg Packaging Label (4879)

Cenestin® 0.625 mg Packaging Label (4879)
Cenestin 0.625 mg tablets packaging label from Physicians Total Care, Inc. The label indicates the product contains synthetic conjugated estrogens with 30 tablets per bottle. It includes cautionary information about federal law prohibiting dispensing without prescription, directions for use, storage instructions to keep the content in a child-resistant container and at controlled room temperature, and lot and expiration details.*
FDA Label Image

Cenestin® 0.45 mg Packaging Label (5415)

Cenestin® 0.45 mg Packaging Label (5415)
Cenestin 0.45 mg tablets label from Physicians Total Care, Inc. The label shows the product name, strength, dosage form as tablets, and a package count of 30 tablets. It specifies that Cenestin contains synthetic conjugated estrogens and includes cautionary dispensing information and storage instructions. The label displays the NDC number, lot number, and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.